4-Vinyl-2,3-dihydrobenzofuran is an intermediate in the synthesis of tasimelteon (T007740). Tasimelteon is a novel drug, used in the treatment of non-24 hour sleep-wake disorder. It helps to correct the circadian rhythm disorder often seen in patients who are visually impaired.
参考文献
Lahon, J. et al.: World. J. Pharm. Res., 3, 1521 (2014);
沪ICP备17019645号
400-821-0725
